Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11Thoracic 2Sarcoma 2Head & Neck 2CNS 2Other solid neoplasm 1Other neoplasm 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Precancerous Conditions 2Esophageal Neoplasms 1Barrett Esophagus 1

Interventions

Endoscopy 2Biopsy 2Immunohistochemistry 1High-Throughput Screening Assays 1Genetic Linkage 1Esomeprazole 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Endoscopic Mucosal Resection 1Comparative Genomic Hybridization 1Aspirin 12-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Erlotinib Hydrochloride × Other neoplasm × Clear all
NCT00566800 2013-09-17

Erlotinib in Treating Patients With Barrett Esophagus

National Cancer Institute (NCI)

Phase 1 Unknown
25 enrolled
GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡